I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 12 studies | 29% ± 9% | |
| astrocyte | 11 studies | 29% ± 15% | |
| glutamatergic neuron | 10 studies | 39% ± 23% | |
| oligodendrocyte | 10 studies | 28% ± 10% | |
| microglial cell | 9 studies | 25% ± 9% | |
| oligodendrocyte precursor cell | 8 studies | 25% ± 12% | |
| GABAergic neuron | 8 studies | 36% ± 22% | |
| fibroblast | 7 studies | 20% ± 5% | |
| macrophage | 6 studies | 25% ± 8% | |
| neuron | 5 studies | 31% ± 12% | |
| epithelial cell | 5 studies | 33% ± 9% | |
| adipocyte | 5 studies | 21% ± 3% | |
| cardiac muscle cell | 4 studies | 16% ± 1% | |
| lymphocyte | 4 studies | 22% ± 6% | |
| goblet cell | 4 studies | 27% ± 17% | |
| interneuron | 4 studies | 44% ± 22% | |
| GABAergic interneuron | 3 studies | 22% ± 3% | |
| retinal ganglion cell | 3 studies | 38% ± 12% | |
| retinal cone cell | 3 studies | 17% ± 2% | |
| ciliated cell | 3 studies | 29% ± 2% | |
| myeloid cell | 3 studies | 17% ± 1% | |
| type I pneumocyte | 3 studies | 20% ± 4% | |
| type II pneumocyte | 3 studies | 22% ± 5% | |
| abnormal cell | 3 studies | 29% ± 7% | |
| endothelial cell of lymphatic vessel | 3 studies | 22% ± 3% | |
| smooth muscle cell | 3 studies | 16% ± 1% | |
| basal cell | 3 studies | 30% ± 13% | |
| transit amplifying cell | 3 studies | 32% ± 16% | |
| granule cell | 3 studies | 20% ± 3% |
